Evopoint Biosciences Co., Ltd. (SHA:688837)
China flag China · Delayed Price · Currency is CNY
33.98
-1.23 (-3.49%)
Nov 17, 2026, 3:00 PM CST

Evopoint Biosciences Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22
Net Income
-453.17202.56-386-426.89-462.63
Depreciation & Amortization
40.3940.3925.8817.6214.91
Other Amortization
4.164.164.925.74.79
Loss (Gain) From Sale of Assets
----0.050.1
Asset Writedown & Restructuring Costs
0.040.04-00.14-0
Loss (Gain) From Sale of Investments
-156.8-156.8-64.62-19.87-48.83
Stock-Based Compensation
140.73140.7317.0934.0558.75
Other Operating Activities
29.5929.6115.737.07-5.51
Change in Accounts Receivable
-58.21-58.21-21.83-6.9714.42
Change in Accounts Payable
-24.16-24.1659.3418.665.45
Operating Cash Flow
-477.43178.3-349.49-370.55-418.55
Operating Cash Flow Growth
-----

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22
Capital Expenditures
-52.43-62.64-50.08-90.13-162.2
Sale of Property, Plant & Equipment
0-00-
Investment in Securities
-334.9923.83214.2615.2690.47
Other Investing Activities
0.672.9313.325.539.15
Investing Cash Flow
-386.75-35.88177.51-69.34-62.58

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22
Long-Term Debt Issued
-767.31176.2128.98329.92
Long-Term Debt Repaid
--409.39-59.01-63.9-2.6
Net Debt Issued (Repaid)
385.66357.92117.1965.08327.32
Issuance of Common Stock
1,706-150512-
Common Dividends Paid
-31.22-24.08-16.34-13.75-5.67
Other Financing Activities
-26.13-15.87-8.55-10.75-5.73
Financing Cash Flow
2,035317.96242.3552.58315.92

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22
Foreign Exchange Rate Adjustments
-4.83-4.18-0.541.139.52
Net Cash Flow
1,166456.2169.78113.83-155.7

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22
Free Cash Flow
-529.87115.66-399.57-460.68-580.75
Free Cash Flow Growth
-----
Free Cash Flow Margin
-225.72%12.37%---2978.22%
Free Cash Flow Per Share
-1.430.31-1.09-1.35-1.78
Levered Free Cash Flow
-141.04-260.68-294.22-
Unlevered Free Cash Flow
-155.96-250.75-289.35-

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22
Cash Income Tax Paid
2.08-7.680.29-24.79-43.3
Change in Working Capital
-82.37-82.3737.5111.6919.88